CARLY SAYERS: Open Payments
NPI 1336556653 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,009 in 156 payments from 21 companies in 2025. Trend: 2023 $1,381 · 2024 $1,404 · 2025 $3,009
Food & beverage: $2,925Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $715 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 35 | $443 |
| Janssen Biotech, Inc. | 15 | $317 |
| Ardelyx, Inc. | 15 | $209 |
| Lilly USA, LLC | 11 | $200 |
| Madrigal Pharmaceuticals | 7 | $169 |
| GENZYME CORPORATION | 6 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $153 |
| Boston Scientific Corporation | 1 | $118 |
| Mallinckrodt Hospital Products Inc. | 1 | $93 |
Products named: XIFAXAN, TREMFYA, RINVOQ, DUPIXENT, IBSRELA, OMVOH, REZDIFFRA, LINZESS.
Industry payments across GA — which companies pay providers there.
